Institutional investors hold a majority ownership of AGN through the 94.41% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended June 2014, these large investors purchased a net $21.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 8.3 Million shares of Allergan Inc
JACKSON SQUARE PARTNERS LLC Bought 6.7 Million shares of Allergan Inc
PAULSON & CO., INC. Bought 5.6 Million shares of Allergan Inc